Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Aug 17, 2022

Accession no.
0001447362-22-000141
Filed
Aug 17, 2022
Trade date
Aug 15-16, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions. Open-market sales total $624.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2022Common StockSSaleDisposed−6,665$33.38F2−$222,477.7317,870Direct
Aug 15, 2022Common StockSSaleDisposed−3,304$33.38F2−$110,287.52143,304Indirect
Aug 15, 2022Common StockSSaleDisposed−3,223$33.38F2−$107,583.74130,908Indirect
Aug 15, 2022Common StockSSaleDisposed−661$33.38F2−$22,064.1829,092Indirect
Aug 15, 2022Common StockSSaleDisposed−662$33.38F2−$22,097.5629,090Indirect
Aug 15, 2022Common StockSSaleDisposed−662$33.38F2−$22,097.5629,090Indirect
Aug 15, 2022Common StockSSaleDisposed−661$33.38F2−$22,064.1829,091Indirect
Aug 15, 2022Common StockSSaleDisposed−50$33.98F9−$1,699317,820Direct
Aug 15, 2022Common StockSSaleDisposed−25$33.98F9−$849.5143,279Indirect
Aug 15, 2022Common StockSSaleDisposed−24$33.98F9−$815.52130,884Indirect
Aug 15, 2022Common StockSSaleDisposed−5$33.98F9−$169.929,087Indirect
Aug 15, 2022Common StockSSaleDisposed−5$33.98F9−$169.929,085Indirect
Aug 15, 2022Common StockSSaleDisposed−5$33.98F9−$169.929,085Indirect
Aug 15, 2022Common StockSSaleDisposed−6$33.98F9−$203.8829,085Indirect
Aug 16, 2022Common StockSSaleDisposed−996$30.63F10−$30,507.48316,824Direct
Aug 16, 2022Common StockSSaleDisposed−487$30.63F10−$14,916.81142,792Indirect
Aug 16, 2022Common StockSSaleDisposed−455$30.63F10−$13,936.65130,429Indirect
Aug 16, 2022Common StockSSaleDisposed−97$30.63F10−$2,971.1128,990Indirect
Aug 16, 2022Common StockSSaleDisposed−97$30.63F10−$2,971.1128,988Indirect
Aug 16, 2022Common StockSSaleDisposed−97$30.63F10−$2,971.1128,988Indirect
Aug 16, 2022Common StockSSaleDisposed−98$30.63F10−$3,001.7428,987Indirect
Aug 16, 2022Common StockSSaleDisposed−249$31.91F11−$7,945.59316,575Direct
Aug 16, 2022Common StockSSaleDisposed−122$31.91F11−$3,893.02142,670Indirect
Aug 16, 2022Common StockSSaleDisposed−114$31.91F11−$3,637.74130,315Indirect
Aug 16, 2022Common StockSSaleDisposed−24$31.91F11−$765.8428,966Indirect
Aug 16, 2022Common StockSSaleDisposed−24$31.91F11−$765.8428,964Indirect
Aug 16, 2022Common StockSSaleDisposed−24$31.91F11−$765.8428,964Indirect
Aug 16, 2022Common StockSSaleDisposed−25$31.91F11−$797.7528,962Indirect
Aug 16, 2022Common StockSSaleDisposed−43$32.83−$1,411.69316,532Direct
Aug 16, 2022Common StockSSaleDisposed−21$32.83−$689.43142,649Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $32.97 to $33.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $33.98 to $33.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $30.36 to $31.35, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

F11

This transaction was executed in multiple trades at prices ranging from $31.36 to $32.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 7 transactions in Table I.

Remarks

This Form 4 is the first of two Form 4s being filed by the Reporting Person relating to the same event. The Form 4 has been split into two filings to cover all 35 individual transactions that occurred on the same Transaction Date, because the SEC's EDGAR filing system limits a single Form 4 to a maximum of 30 separate transactions.

Read the full filing on SEC EDGAR (opens in a new tab)